4//SEC Filing
Brennan Peter F 4
Accession 0001615774-18-001625
CIK 0000102198other
Filed
Mar 5, 7:00 PM ET
Accepted
Mar 6, 1:08 PM ET
Size
16.9 KB
Accession
0001615774-18-001625
Insider Transaction Report
Form 4
Brennan Peter F
Director
Transactions
- Exercise/Conversion
Common Stock
2018-02-12+4,594,117→ 13,850,181 total - Conversion
Warrant
2018-02-12$0.60/sh+123,530$74,118→ 123,530 totalExercise: $0.60→ Common Stock (123,530 underlying) - Conversion
Warrant
2018-02-12$0.60/sh+411,765$247,059→ 535,295 totalExercise: $0.60→ Common Stock (411,765 underlying) - Conversion
Warrant
2018-02-12$0.13/sh+764,706$99,412→ 1,300,001 totalExercise: $0.13→ Common Stock (764,706 underlying) - Conversion
Warrant
2018-02-12$0.13/sh+1,882,362$244,707→ 3,182,353 totalExercise: $0.13→ Common Stock (1,882,362 underlying) - Conversion
Warrant
2018-02-12$0.13/sh+1,411,765$176,471→ 4,594,117 totalExercise: $0.13→ Common Stock (1,411,765 underlying)
Footnotes (5)
- [F1]The Reporting Person received a warrant to purchase 123,530 shares of Common Stock on 02/23/2017 inconnection with a Note Purchase Agreement executed on that date. The exercise price was $0.60 per share. The warrant was exercisable immediately and expired in one year-02/23/2018.
- [F2]The Reporting Person received a warrant to purchase 411,765 shares of Common Stock on 05/16/2017 in connection with a Note Purchase Agreement executed on that date. The exercise price was $0.60 per share. The warrant was exercisable immediately and expired in one year-05/16/2018.
- [F3]The Reporting Person received a warrant to purchase 764,706 shares of Common Stock on 07/24/2017 in connection with a Note Purchase Agreement executed on that date. The exercise price was $0.13 per share. The warrant was exercisable immediately and expired in one year - 07/24/2018.
- [F4]The Reporting Person received a warrant to purchase 1,882,352 shares of Common Stock on 12/29/2017 in connection with a Note Purchase Agreement executed on that date. The exercise price was $0.13 per share. The warrant was exercisable immediately and expired in one year-12/29/2018.
- [F5]The Reporting Person received a warrant to purchase 1,411,765 shares of Common Stock on 02/01/2018 in connection with a Note Purchase Agreement executed on that date. The exercise price was $0.125 per share. The warrant was exercisable immediately and expired in one year- 02/01/2019.
Documents
Issuer
CALMARE THERAPEUTICS Inc
CIK 0000102198
Entity typeother
Related Parties
1- filerCIK 0001501353
Filing Metadata
- Form type
- 4
- Filed
- Mar 5, 7:00 PM ET
- Accepted
- Mar 6, 1:08 PM ET
- Size
- 16.9 KB